AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 22107037 — intervention group
Group type: EXPERIMENTAL
Intervention: No imbedded supportive message
Number of subjects: 179
Study 19444731 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual outpatient alcoholism treatment
Number of subjects: 102
Study 19444731 — intervention group
Group type: COMPARATOR
Intervention: Couples outpatient alcoholism treatment
Number of subjects: 102
Study 17327253 — intervention group
Group type: EXPERIMENTAL
Intervention: Counter-flow-type humidifier
Number of subjects: 12
Study 17327253 — intervention group
Group type: COMPARATOR
Intervention: Conventional heated humidifier
Number of subjects: 12
Study 17327253 — intervention group
Group type: COMPARATOR
Intervention: Passive heat and moisture exchanger (HME)
Number of subjects: 12
Study 15206990 — intervention group
Group type: EXPERIMENTAL
Intervention: levocetirizine 5 mg
Number of subjects: 15
Study 15206990 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 15
Study 12364460 — intervention group
Group type: EXPERIMENTAL
Intervention: GH 1 micro g/kg
Number of subjects: 18
Study 12364460 — intervention group
Group type: EXPERIMENTAL
Intervention: GH 3 micro g/kg
Number of subjects: 18
Study 12364460 — intervention group
Group type: EXPERIMENTAL
Intervention: GH 6 micro g/kg
Number of subjects: 18
Study 12364460 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 9481346 — intervention group
Group type: EXPERIMENTAL
Intervention: LSU pamphlet
Number of subjects: 610
Study 9481346 — intervention group
Group type: COMPARATOR
Intervention: CDC pamphlet
Number of subjects: 610
Study 8021626 — intervention group
Group type: EXPERIMENTAL
Intervention: Bright colors (e.g., pink, blue, red)
Number of subjects: 60
Study 8021626 — intervention group
Group type: EXPERIMENTAL
Intervention: Dark colors (e.g., brown, black, gray)
Number of subjects: 60
Study 8021626 — intervention group
Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 60
Study 8021626 — intervention group
Group type: EXPERIMENTAL
Intervention: Gender
Number of subjects: 60
Study 2688780 — intervention group
Group type: EXPERIMENTAL
Intervention: Prescriptive treatment
Number of subjects: 0
Study 2688780 — intervention group
Group type: COMPARATOR
Intervention: Exploratory treatment
Number of subjects: 0
Study 980598 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-saturated-fat, low-cholesterol (LSFLC) diet
Number of subjects: 0
Study 980598 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 31146039 — intervention group
Group type: EXPERIMENTAL
Intervention: Subthalamic nucleus (STN) deep brain stimulation (DBS)
Number of subjects: 42
Study 31146039 — intervention group
Group type: EXPERIMENTAL
Intervention: Globus pallidus internus (GPi) deep brain stimulation (DBS)
Number of subjects: 42
Study 31146039 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined factors of disease duration and stimulation type
Number of subjects: 42
Study 26518352 — intervention group
Group type: EXPERIMENTAL
Intervention: Electric fan therapy
Number of subjects: 30
Study 26518352 — intervention group
Group type: COMPARATOR
Intervention: Control group (routine treatment)
Number of subjects: 30
Study 25724154 — intervention group
Group type: EXPERIMENTAL
Intervention: ALO‐02 with 20 % ethanol
Number of subjects: 18
Study 25724154 — intervention group
Group type: EXPERIMENTAL
Intervention: ALO‐02 with 40 % ethanol
Number of subjects: 18
Study 25724154 — intervention group
Group type: COMPARATOR
Intervention: ALO‐02 with water
Number of subjects: 18
Study 23941470 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise-based programme (ARNI), 24 hours of one-to-one training by an Exercise Professional, plus at least 2 hours weekly unsupervised exercise, over 12-14 weeks
Number of subjects: 6
Study 23941470 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise-based programme (ARNI)
Number of subjects: 6
Study 21675444 — intervention group
Group type: EXPERIMENTAL
Intervention: Silver mesh dressing (Tegaderm Ag Mesh dressing), changed every three days
Number of subjects: 40
Study 21675444 — intervention group
Group type: COMPARATOR
Intervention: Silver sulfadiazine cream, changed twice a day
Number of subjects: 40
Study 21675444 — intervention group
Group type: EXPERIMENTAL
Intervention: Silver mesh dressing (Tegaderm Ag Mesh dressing)
Number of subjects: 40
Study 21675444 — intervention group
Group type: COMPARATOR
Intervention: Silver sulfadiazine cream
Number of subjects: 40
Study 18608103 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine monohydrate (5 g/d)
Number of subjects: 107
Study 18608103 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 107
Study 16198215 — intervention group
Group type: EXPERIMENTAL
Intervention: Relational system with relational behaviors
Number of subjects: 91
Study 16198215 — intervention group
Group type: EXPERIMENTAL
Intervention: Identical system with relational behaviors ablated
Number of subjects: 91
Study 16198215 — intervention group
Group type: COMPARATOR
Intervention: Control system
Number of subjects: 91
Study 12401636 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg of neostigmine plus 3 mg/kg of prilocaine diluted with saline to a total dose of 40 mL
Number of subjects: 30
Study 12401636 — intervention group
Group type: COMPARATOR
Intervention: 1 mL of saline plus 3 mg/kg of prilocaine diluted with saline to a total dose of 40 mL
Number of subjects: 30
Study 9932993 — intervention group
Group type: EXPERIMENTAL
Intervention: Previous argon laser trabeculoplasty
Number of subjects: 498
Study 9932993 — intervention group
Group type: COMPARATOR
Intervention: No previous argon laser trabeculoplasty
Number of subjects: 498
Study 9932993 — intervention group
Group type: EXPERIMENTAL
Intervention: Eyes with encapsulated bleb
Number of subjects: 498
Study 9932993 — intervention group
Group type: COMPARATOR
Intervention: Eyes without encapsulated bleb
Number of subjects: 498
Study 9932993 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups after 1 year
Number of subjects: 498
Study 7778354 — intervention group
Group type: EXPERIMENTAL
Intervention: beta-hydroxyethyl rutosides
Number of subjects: 51
Study 7778354 — intervention group
Group type: COMPARATOR
Intervention: physical therapy (cold foot-baths)
Number of subjects: 51
Study 7778354 — intervention group
Group type: COMPARATOR
Intervention: control group (only examination)
Number of subjects: 51
Study 2320648 — intervention group
Group type: EXPERIMENTAL
Intervention: ketocyclazocine
Number of subjects: 10
Study 2320648 — intervention group
Group type: EXPERIMENTAL
Intervention: morphine
Number of subjects: 10
Study 2320648 — intervention group
Group type: EXPERIMENTAL
Intervention: cyclazocine
Number of subjects: 10
Study 2320648 — intervention group
Group type: COMPARATOR
Intervention: naloxone
Number of subjects: 10
Study 2320648 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 10
Study 647213 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose insulin infusion (2.6 U/h)
Number of subjects: 6
Study 647213 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose insulin infusion (10.6 U/h)
Number of subjects: 6
Study 647213 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion (control)
Number of subjects: 6
Study 647213 — intervention group
Group type: EXPERIMENTAL
Intervention: Both insulin infusions (low and high dose)
Number of subjects: 6
Study 29462095 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical testosterone applied 3 times a week for 12 weeks
Number of subjects: 60
Study 29462095 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical estrogen applied 3 times a week for 12 weeks
Number of subjects: 60
Study 29462095 — intervention group
Group type: COMPARATOR
Intervention: Placebo applied 3 times a week for 12 weeks
Number of subjects: 60
Study 27516420 — intervention group
Group type: COMPARATOR
Intervention: PDT (Photodynamic Therapy)
Number of subjects: 15
Study 27516420 — intervention group
Group type: EXPERIMENTAL
Intervention: PDL-PDT (Pulsed Dye Laser-mediated Photodynamic Therapy)
Number of subjects: 15
Study 24738516 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human growth hormone and testosterone enanthate injections
Number of subjects: 14
Study 24738516 — intervention group
Group type: COMPARATOR
Intervention: Physical activity programme
Number of subjects: 14
Study 24107856 — intervention group
Group type: EXPERIMENTAL
Intervention: HEALTHY nutrition intervention
Number of subjects: 0
Study 20097333 — intervention group
Group type: EXPERIMENTAL
Intervention: Spontaneous LH group
Number of subjects: 124
Study 20097333 — intervention group
Group type: COMPARATOR
Intervention: hCG group
Number of subjects: 124
Study 18422205 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug-eluting stents (DES)
Number of subjects: 0
Study 18422205 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term anti-platelet therapy
Number of subjects: 0
Study 16316859 — intervention group
Group type: EXPERIMENTAL
Intervention: Dozozin‐2 (test formulation)
Number of subjects: 24
Study 16316859 — intervention group
Group type: COMPARATOR
Intervention: Cardura (reference formulation)
Number of subjects: 24
Study 12752522 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (BTX‐A) reconstituted over 6 consecutive weeks, injected after reconstitution.
Number of subjects: 85
Study 11128850 — intervention group
Group type: EXPERIMENTAL
Intervention: CHO treatment (glucose 60 g x L(‐1))
Number of subjects: 15
Study 11128850 — intervention group
Group type: COMPARATOR
Intervention: PLA treatment (placebo drink)
Number of subjects: 15
Study 11128850 — intervention group
Group type: COMPARATOR
Intervention: RFI treatment (restricted fluid intake with 200 mL placebo)
Number of subjects: 15
Study 9263617 — intervention group
Group type: EXPERIMENTAL
Intervention: G30 + 100 (training with five repetitions at 30% maximum strength and five isometric contractions at 100% Fmax)
Number of subjects: 12
Study 9263617 — intervention group
Group type: COMPARATOR
Intervention: G30 + 0 (training with five repetitions at 30% maximum strength and five contractions with no load)
Number of subjects: 12
Study 8477114 — intervention group
Group type: EXPERIMENTAL
Intervention: PenFill
Number of subjects: 14
Study 8477114 — intervention group
Group type: EXPERIMENTAL
Intervention: PenSet
Number of subjects: 14
Study 8477114 — intervention group
Group type: COMPARATOR
Intervention: Both formulations
Number of subjects: 14
Study 3698655 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg naftidrofuryl daily
Number of subjects: 61
Study 3698655 — intervention group
Group type: COMPARATOR
Intervention: Identical placebo
Number of subjects: 61
Study 29801123 — intervention group
Group type: EXPERIMENTAL
Intervention: Lampalizumab every 4 weeks (Chroma)
Number of subjects: 1881
Study 29801123 — intervention group
Group type: EXPERIMENTAL
Intervention: Lampalizumab every 4 weeks (Spectri)
Number of subjects: 1881
Study 29801123 — intervention group
Group type: EXPERIMENTAL
Intervention: Lampalizumab every 6 weeks (Chroma)
Number of subjects: 1881
Study 29801123 — intervention group
Group type: EXPERIMENTAL
Intervention: Lampalizumab every 6 weeks (Spectri)
Number of subjects: 1881
Study 29801123 — intervention group
Group type: COMPARATOR
Intervention: Sham procedure every 4 weeks (pooled)
Number of subjects: 1881
Study 29801123 — intervention group
Group type: COMPARATOR
Intervention: Sham procedure every 6 weeks (pooled)
Number of subjects: 1881
Study 26751236 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytoreductive surgery and intraperitoneal chemotherapy (5-fluorouracil 550 mg/m²/d for 6 days, repeated monthly for 6 months)
Number of subjects: 48
Study 26751236 — intervention group
Group type: COMPARATOR
Intervention: Systemic chemotherapy (oxaliplatin and 5-fluorouracil regimen every second week for 6 months)
Number of subjects: 48
Study 26751236 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytoreductive surgery and intraperitoneal chemotherapy
Number of subjects: 48
Study 26751236 — intervention group
Group type: COMPARATOR
Intervention: Systemic chemotherapy
Number of subjects: 48
Study 25323203 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrative Exposure Therapy (NET-1)
Number of subjects: 76
Study 25323203 — intervention group
Group type: COMPARATOR
Intervention: Waiting List (WL) followed by NET (WL/NET-2)
Number of subjects: 76
Study 22661123 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenosine 25 μg/kg/min
Number of subjects: 166
Study 22661123 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenosine 50 μg/kg/min
Number of subjects: 166
Study 22661123 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenosine 100 μg/kg/min
Number of subjects: 166
Study 22661123 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenosine 200 μg/kg/min
Number of subjects: 166
Study 22661123 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 166
Study 20013816 — intervention group
Group type: EXPERIMENTAL
Intervention: SheaFlex70
Number of subjects: 89
Study 18613854 — intervention group
Group type: EXPERIMENTAL
Intervention: Epoetin beta with concomitant IV iron
Number of subjects: 0
Study 18613854 — intervention group
Group type: COMPARATOR
Intervention: Epoetin beta without IV iron
Number of subjects: 0
Study 16082013 — intervention group
Group type: EXPERIMENTAL
Intervention: Dive rolls
Number of subjects: 14
Study 16082013 — intervention group
Group type: EXPERIMENTAL
Intervention: Back-handsprings
Number of subjects: 14
Study 12075944 — intervention group
Group type: EXPERIMENTAL
Intervention: Granisetron 3 mg
Number of subjects: 80
Study 12075944 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramosetron 0.3 mg
Number of subjects: 80
Study 10621537 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonsteroidal anti-inflammatory drugs for inflamed pterygia
Number of subjects: 0
Study 10621537 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery for pterygium
Number of subjects: 0
Study 9295497 — intervention group
Group type: EXPERIMENTAL
Intervention: Food intake during intestinal preparation
Number of subjects: 60
Study 9295497 — intervention group
Group type: COMPARATOR
Intervention: Fasting during intestinal preparation
Number of subjects: 60
Study 1496965 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine (10 mg)
Number of subjects: 13
Study 1496965 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril (25 mg)
Number of subjects: 13
Study 1496965 — intervention group
Group type: COMPARATOR
Intervention: Control (no medication)
Number of subjects: 13
Study 6741665 — intervention group
Group type: EXPERIMENTAL
Intervention: Master Questionnaire (MQ)
Number of subjects: 0
Study 6741665 — intervention group
Group type: EXPERIMENTAL
Intervention: Energy Balance Knowledge and Cognitive Factors subscales
Number of subjects: 0
Study 6741665 — intervention group
Group type: EXPERIMENTAL
Intervention: Five new subscales developed from cluster and factor analyses
Number of subjects: 0
Study 31215460 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive insulin therapy (intravenous continuous infusion of regular human insulin at a rate of 0.1 units/kg·h to 0.3 units/kg·h)
Number of subjects: 220
Study 31215460 — intervention group
Group type: COMPARATOR
Intervention: Plasmapheresis (standard-volume plasmapheresis)
Number of subjects: 220
Study 31215460 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive insulin therapy
Number of subjects: 220
Study 31215460 — intervention group
Group type: COMPARATOR
Intervention: Plasmapheresis
Number of subjects: 220
Study 28902683 — intervention group
Group type: EXPERIMENTAL
Intervention: EOV determination through blinded review by six individuals
Number of subjects: 243
Study 28902683 — intervention group
Group type: EXPERIMENTAL
Intervention: EOV determination using ventilation dispersion index (VDI)
Number of subjects: 243
Study 28902683 — intervention group
Group type: EXPERIMENTAL
Intervention: Prevalence rates of positive and indeterminate EOVs with 10‐s discrete averages
Number of subjects: 243
Study 28902683 — intervention group
Group type: EXPERIMENTAL
Intervention: Prevalence rates of positive and indeterminate EOVs with 30‐s rolling averages
Number of subjects: 243
Study 27530359 — intervention group
Group type: COMPARATOR
Intervention: Macintosh laryngoscope
Number of subjects: 0
Study 27530359 — intervention group
Group type: EXPERIMENTAL
Intervention: C-MAC with D-Blade
Number of subjects: 0
Study 27530359 — intervention group
Group type: EXPERIMENTAL
Intervention: A.P. Advance with difficult airway blade
Number of subjects: 0
Study 27530359 — intervention group
Group type: EXPERIMENTAL
Intervention: Airtraq with wireless video-viewer
Number of subjects: 0
Study 23911102 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical application of injectable form of tranexamic acid (500 mg in 5 mL)
Number of subjects: 216
Study 23911102 — intervention group
Group type: COMPARATOR
Intervention: Anterior nasal packing with pledgets coated with tetracycline ointment
Number of subjects: 216
Study 21596621 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative short-term radiotherapy (5 × 5 Gy) combined with total mesorectal excision (TME)
Number of subjects: 1861
Study 21596621 — intervention group
Group type: COMPARATOR
Intervention: Total mesorectal excision (TME) alone
Number of subjects: 1861
Study 21596621 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative short-term radiotherapy (5 × 5 Gy) combined with TME
Number of subjects: 1861
Study 19356743 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine cognitive behavioral therapy (CBT)
Number of subjects: 128
Study 19356743 — intervention group
Group type: COMPARATOR
Intervention: Face-to-face cognitive behavioral therapy (CBT)
Number of subjects: 128
Study 16910866 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.4% ketorolac tromethamine ophthalmic solution
Number of subjects: 40
Study 16910866 — intervention group
Group type: COMPARATOR
Intervention: 0.5% ketorolac tromethamine ophthalmic solution
Number of subjects: 40
Study 14962400 — intervention group
Group type: EXPERIMENTAL
Intervention: Key-pressing actions producing auditory effects; no specific dosage or duration mentioned
Number of subjects: 0
Study 12061017 — intervention group
Group type: EXPERIMENTAL
Intervention: High-strength glass ionomer/resin composite restoration technique
Number of subjects: 0
Study 12061017 — intervention group
Group type: COMPARATOR
Intervention: Two occlusal resin composite restoration techniques
Number of subjects: 0
Study 9232045 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous penicillin G sodium, 250,000 U/kg every 24 hours
Number of subjects: 42
Study 8355866 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral droperidol
Number of subjects: 75
Study 8355866 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral diazepam plus droperidol
Number of subjects: 75
Study 8355866 — intervention group
Group type: COMPARATOR
Intervention: Oral diazepam
Number of subjects: 75
Study 3311134 — intervention group
Group type: EXPERIMENTAL
Intervention: Artificial insemination with husband's semen (high AIH)
Number of subjects: 46
Study 3311134 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 46
Study 29167877 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine (0.23 mg/kg infusion over 1 minute followed by 0.58 mg/kg/h infusion over 30 minutes and then 0.29 mg/kg/h infusion over 29 minutes)
Number of subjects: 65
Study 29167877 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine
Number of subjects: 65
Study 29167877 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study 27608437 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 409
Study 27608437 — intervention group
Group type: EXPERIMENTAL
Intervention: BRV 50mg/day
Number of subjects: 409
Study 27608437 — intervention group
Group type: EXPERIMENTAL
Intervention: BRV 100mg/day
Number of subjects: 409
Study 27608437 — intervention group
Group type: EXPERIMENTAL
Intervention: BRV 200mg/day
Number of subjects: 409
Study 24366670 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetylpyridinium chloride 0.05 % (CPC; Cepacol™)
Number of subjects: 52
Study 24366670 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine 0.12 % (CHX; Periogard™)
Number of subjects: 52
Study 24366670 — intervention group
Group type: COMPARATOR
Intervention: Sterile tap water (Control)
Number of subjects: 52
Study 23845104 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioural therapy for insomnia (CBT-I)
Number of subjects: 60
Study 23845104 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 60
Study 20103540 — intervention group
Group type: EXPERIMENTAL
Intervention: Celiac plexus block with 25 mL bupivacaine 0.25%
Number of subjects: 19
Study 20103540 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 19
Study 18928102 — intervention group
Group type: EXPERIMENTAL
Intervention: Paidu Baoshen Pill (PBP) 3 g twice a day
Number of subjects: 283
Study 18928102 — intervention group
Group type: COMPARATOR
Intervention: Oxidative amylase aldehyde enveloped capsule 5-10 capsules thrice a day
Number of subjects: 283
Study 18928102 — intervention group
Group type: EXPERIMENTAL
Intervention: Paidu Baoshen Pill (PBP)
Number of subjects: 283
Study 21344828 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluorshield (Dentsply) sealant
Number of subjects: 60
Study 21344828 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 60
Study 16386522 — intervention group
Group type: EXPERIMENTAL
Intervention: Basiliximab (20 mg/day) on days 0 and 4 posttransplant
Number of subjects: 49
Study 16386522 — intervention group
Group type: EXPERIMENTAL
Intervention: Daclizumab (1 mg/kg per day) on days 0 and 15 posttransplant
Number of subjects: 49
Study 16386522 — intervention group
Group type: EXPERIMENTAL
Intervention: Posttransplant dialysis
Number of subjects: 49
Study 16386522 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine (CsA) introduction
Number of subjects: 49
Study 16386522 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus introduction
Number of subjects: 49
Study 16386522 — intervention group
Group type: EXPERIMENTAL
Intervention: Kidney graft loss
Number of subjects: 49
Study 16386522 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient survival
Number of subjects: 49
Study 16386522 — intervention group
Group type: EXPERIMENTAL
Intervention: Functioning grafts
Number of subjects: 49
Study 16386522 — intervention group
Group type: EXPERIMENTAL
Intervention: Interleukin-2-receptor blockade
Number of subjects: 49
Study 12217279 — intervention group
Group type: EXPERIMENTAL
Intervention: Closure with application of fibrin glue (group B)
Number of subjects: 224
Study 12217279 — intervention group
Group type: COMPARATOR
Intervention: Standard closure (group A)
Number of subjects: 224
Study 9930597 — intervention group
Group type: EXPERIMENTAL
Intervention: Acellular pertussis vaccine (24% PT-IgE at 7 months)
Number of subjects: 189